Bavarian Nordic A/S
Bavarian Nordic A/S
-0,06 %
173,70 DKK
-0,10
Kurs
173,70
Høj
175,00
Ændring
-0,06 %
Lav
172,50
Opdateret
21-09-2018
Åben
174,95
Nyheder om Bavarian Nordic A/S
Factsheet for Bavarian Nordic A/S
Company Profile
Description
Bavarian Nordic is a biotechnology company focused on the development, manufacturing, and commercialization of cancer immunotherapies and vaccines for infectious diseases. The company has a specific focus on diseases for which the unmet medical need is high. Bavarian generates revenue through government research and development and supply contracts, and from its commercial partnerships. The vast majority of the company's revenue is generated in the Netherlands, followed by the United States, Canada, and other geographic markets.
Key Stats
Website: http://www.bavarian-nordic.com
Headquarter country: Denmark
Employees: 449
Market Cap (at close 21-09-2018): DKK 6B
Fiscal Year Ends: december
Stats

Stats 2017 2016 2015 2014 2013
Price/Earnings 15,60 123,80 60,60
Forward Price/Earnings 6,40 13,30 13,40 263,20
Price/Free Cash Flow 7,30 163,80 12,80 973,70 19,20
Return on Assets 6,10 1,30 3,10 1,60 -3,10
Return on Equity 8,00 1,80 4,60 2,30 -4,70
Return on Invested Capital 7,40 1,90 4,60 2,50 -4,00
Dividend


Dividend/Share:
Ex. Dividend Date:01-01-0001
Trailing Dividend Yield:
Payout Ratio:0,00
Date Currency Amount
Income Statement

Revenue 2017 2016 2015 2014 2013
Total Revenue 1.370,00 1.007,00 1.021,00 1.217,00 1.213,00
Gross Profit 1,08 0,710 0,610 0,720 0,730
Gross Margin % 78,79% 70,42% 59,32% 59,31% 60,02%
Operating Expenses 2017 2016 2015 2014 2013
EBITDA 415,00 157,00 127,00 159,00 205,00
Net income 181,00 31,00 59,00 26,00 -47,00
Basic Earnings Per Share 5,70 1,00 2,10 1,00 -1,80
Operating Income 0,350 0,030 0,00 0,020 0,030
Operating Margin % 25,78% 3,28% 0,150% 1,37% 2,76%
Cash Flow

Cash Flow 2017 2016 2015 2014 2013
Operating Cash Flow 216,00 268,00 105,00 339,00 147,00
Capital Expenditures -79,00 -92,00 -60,00 -106,00 -155,00
Free Cash Flow 137,00 176,00 45,00 233,00 -8,00
Balance Sheet

Assets 31-12-2017 31-12-2016 31-12-2015 31-12-2014 31-12-2013
Current Assets 2.770.485 2.282.567 1.334.189 1.319.123 900.369
Long Term Assets 382.186 541.131 585.005 568.145 551.837
Total Assets 3.152.671 2.823.698 1.989.263 1.887.268 1.452.206
Liabilities 31-12-2017 31-12-2016 31-12-2015 31-12-2014 31-12-2013
Total Current Liabilities 246.614 751.798 590.234 583.278 389.252
Long Term Liabilities 399.760 54.663 56.550
Total Liabilities 646.374 806.461 646.784
Equity 31-12-2017 31-12-2016 31-12-2015 31-12-2014 31-12-2013
Retained Earnings 2.156.883 1.731.898 1.066.558 972.321 652.021
Treasury Stock 233,00 111,00
Total Stockholder Equity 2.506.297 2.017.237 1.342.479 1.252.094 976.290
Net Tangible Assets 2.473.305 1.934.218 1.234.290 1.142.900 871.661